BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 29129848)

  • 1. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
    Hitomi Y; Tokunaga K
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation diagnostics: gene panel, exome, or whole genome?
    Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
    Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
    Smith A; Boycott KM; Jarinova O
    Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel knowledge-derived data potentizing method revealed unique liver cancer-associated genetic variants.
    Sultana N; Rahman M; Myti S; Islam J; Mustafa MG; Nag K
    Hum Genomics; 2019 Jul; 13(1):30. PubMed ID: 31272500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Genome Sequencing of a Canine Family Trio Reveals a FAM83G Variant Associated with Hereditary Footpad Hyperkeratosis.
    Sayyab S; Viluma A; Bergvall K; Brunberg E; Jagannathan V; Leeb T; Andersson G; Bergström TF
    G3 (Bethesda); 2016 Jan; 6(3):521-7. PubMed ID: 26747202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trend of annotating single nucleotide variation in humans--A case study on SNVrap.
    Li MJ; Wang J
    Methods; 2015 Jun; 79-80():32-40. PubMed ID: 25308971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels.
    Klein CJ; Foroud TM
    Mayo Clin Proc; 2017 Feb; 92(2):292-305. PubMed ID: 28160876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.
    Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB
    Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of causal sequence variants of disease in the next generation sequencing era.
    Kingsley CB
    Methods Mol Biol; 2011; 700():37-46. PubMed ID: 21204025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Studies of Genetic Variants Associated with Human Diseases in Notch Signaling-Related Genes Using Drosophila.
    Yang SA; Salazar JL; Li-Kroeger D; Yamamoto S
    Methods Mol Biol; 2022; 2472():235-276. PubMed ID: 35674905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2013 Oct; 79():9.24.1-9.24.24. PubMed ID: 24510652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical guide to filtering and prioritizing genetic variants.
    Jalali Sefid Dashti M; Gamieldien J
    Biotechniques; 2017 Jan; 62(1):18-30. PubMed ID: 28118812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing: Uncovering causal genetic variants for ocular diseases.
    Gupta S; Chatterjee S; Mukherjee A; Mutsuddi M
    Exp Eye Res; 2017 Nov; 164():139-150. PubMed ID: 28844620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
    Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies of genome-wide association study based on high-throughput sequencing].
    Zhou J; Pei Z; Chen Y; Chen R
    Yi Chuan; 2014 Nov; 36(11):1099-111. PubMed ID: 25567868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.